Emergent Biosolutions(DE:ER4)
€5.27-0.09 (-1.68%)
DE:ER4
Emergent Biosolutions earnings date
€5.27
At close:-0.09 (-1.68%)
Emergent Biosolutions (ER4) Q3 2021 Earnings Report
7 Followers
DE:ER4 Q3 2021 EPS Results
- Actual EPS
- -EUR 0.32
- Consensus EPS
- EUR 2.10
- Beat/Miss
- Missed by -EUR 2.42
- One Year Ago EPS
- EUR 1.96
DE:ER4 Q3 2021 Revenue Results
- Actual Revenue
- EUR 294.57M
- Expected Revenue
- EUR 435.89M
- Beat/Miss
- Missed by -EUR 141.32M
- YoY Revenue Growth
- -14.59%
Earnings Announcement Details
- Quarter
- Q3 2021
- Date
- 11/04/2021
- Time
- After Close
- Conference Call
- Thursday, November 4, 2021
DE:ER4 Upcoming Earnings
Emergent Biosolutions's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q3 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:ER4 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.15- | -0.39 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.35-0.32 | 0.95 | -133.96% (-1.27) | |
| Aug 05, 2026 | 2026 (Q2) | -0.080.54 | 0.14 | 275.00% (+0.39) | |
| Apr 30, 2026 | 2026 (Q1) | -0.220.19 | 0.64 | -70.42% (-0.45) | |
| Feb 26, 2026 | 2025 (Q4) | 0.10-0.39 | 0.04 | -960.00% (-0.43) | |
| Oct 29, 2025 | 2025 (Q3) | -0.110.95 | 1.23 | -22.63% (-0.28) | |
| Aug 06, 2025 | 2025 (Q2) | -0.440.14 | -2.08 | 106.90% (+2.22) | |
| May 07, 2025 | 2025 (Q1) | 0.390.64 | 0.53 | 20.34% (+0.11) | |
| Mar 03, 2025 | 2024 (Q4) | -0.450.04 | -0.69 | 106.49% (+0.73) | |
| Nov 06, 2024 | 2024 (Q3) | 0.091.23 | -0.48 | 353.70% (+1.71) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
